Ganciclovir prophylaxis decreases frequency and severity of cytomegalovirus disease in seropositive liver transplant recipients treated with OKT3 monoclonal antibodies.

Two grams daily of oral acyclovir reduces the incidence of cytomegalovirus disease in CMV-seropositive liver transplant recipients

Transplant International ◽

10.1111/j.1432-2277.1997.tb00725.x ◽

1997 ◽

Vol 10 (6) ◽

pp. 462-465 ◽

Cited By ~ 20

Author(s):

J. Gavaldà ◽

J. Otero ◽

A. Pahissa ◽

E. Murio ◽

C. Margarit ◽

...

Keyword(s):

Liver Transplant ◽

Oral Acyclovir ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients

The Lancet ◽

10.1016/s0140-6736(97)05535-9 ◽

1997 ◽

Vol 350 (9093) ◽

pp. 1729-1733 ◽

Cited By ~ 370

Author(s):

Edward Gane ◽

Faouzi Saliba ◽

Garcia JC Valdecasas ◽

John O'Grady ◽

Mark D Pescovitz ◽

...

Keyword(s):

Liver Transplant ◽

Randomised Trial ◽

Oral Ganciclovir ◽

Efficacy And Safety ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽

A PROSPECTIVE RANDOMIZED TRIAL COMPARING SEQUENTIAL GANCICLOVIR-HIGH DOSE ACYCLOVIR TO HIGH DOSE ACYCLOVIR FOR PREVENTION OF CYTOMEGALOVIRUS DISEASE IN ADULT LIVER TRANSPLANT RECIPIENTS

10.1097/00007890-199410150-00005 ◽

1994 ◽

Vol 58 (7) ◽

pp. 779-785 ◽

Cited By ~ 72

Author(s):

Maureen Martin ◽

Rafael Mañez ◽

Peter Linden ◽

David Estores ◽

Julian Torre-Cisneros ◽

...

Keyword(s):

Liver Transplant ◽

Randomized Trial ◽

Prospective Randomized Trial ◽

High Dose ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽

Adult Liver ◽

The Risk Factors for Cytomegalovirus Syndrome and Tissue-invasive Cytomegalovirus Disease in Liver Transplant Recipients Who Have Cytomegalovirus Antigenemia

Transplantation Proceedings ◽

10.1016/j.transproceed.2010.02.041 ◽

2010 ◽

Vol 42 (3) ◽

pp. 890-894 ◽

Cited By ~ 6

Author(s):

J.M. Kim ◽

S.J. Kim ◽

J.-W. Joh ◽

M. Shin ◽

J.I. Moon ◽

...

Keyword(s):

Risk Factors ◽

Liver Transplant ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽

Surveillance Cultures of Blood, Urine, and Throat Specimens Are Not Valuable for Predicting Cytomegalovirus Disease in Liver Transplant Recipients

Clinical Infectious Diseases ◽

10.1093/clinids/24.5.824 ◽

1997 ◽

Vol 24 (5) ◽

pp. 824-829 ◽

Cited By ~ 17

Author(s):

M. E. Falagas ◽

D. R. Snydman ◽

R. Ruthazer ◽

B. G. Werner ◽

J. Griffith ◽

...

Keyword(s):

Liver Transplant ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽

Surveillance Cultures ◽

High-Dose Acyclovir Compared with Short-Course Preemptive Ganciclovir Therapy To Prevent Cytomegalovirus Disease in Liver Transplant Recipients

Annals of Internal Medicine ◽

10.7326/0003-4819-120-5-199403010-00004 ◽

1994 ◽

Vol 120 (5) ◽

pp. 375 ◽

Cited By ~ 138

Author(s):

Nina Singh

Keyword(s):

Liver Transplant ◽

High Dose ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽

Ganciclovir Therapy ◽

Short Course ◽

Efficacy of Valganciclovir Administered as Preemptive Therapy for Cytomegalovirus Disease in Liver Transplant Recipients: Impact on Viral Load and Late-Onset Cytomegalovirus Disease

10.1097/01.tp.0000146844.65273.62 ◽

2005 ◽

Vol 79 (1) ◽

pp. 85-90 ◽

Cited By ~ 93

Author(s):

Nina Singh ◽

Cheryl Wannstedt ◽

Lois Keyes ◽

Timothy Gayowski ◽

Marilyn M. Wagener ◽

...

Keyword(s):

Viral Load ◽

Liver Transplant ◽

Late Onset ◽

Preemptive Therapy ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽

EFFECT OF ORAL ACYCLOVIR OR GANCYCLOVIR AFTER PREEMPTIVE INTRAVENOUS GANCYCLOVIR THERAPY TO PREVENT CYTOMEGALOVIRUS DISEASE IN CYTOMEGALOVIRUS SEROPOSITIVE RENAL AND LIVER TRANSPLANT RECIPIENTS RECEIVING ANTILYMPHOCYTE THERAPY.

10.1097/00007890-199805131-00441 ◽

1998 ◽

Vol 65 (Supplement) ◽

pp. 189

Author(s):

Nathalie Turgeon ◽

Jay A. Fishman ◽

Nesli Basgoz ◽

Nina E. Tolkoff-Rubin ◽

A. Benedict Cosimi ◽

...

Keyword(s):

Liver Transplant ◽

Oral Acyclovir ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽

PREVENTION OF RECURRENT CYTOMEGALOVIRUS DISEASE IN RENAL AND LIVER TRANSPLANT RECIPIENTS; EFFECT OF ORAL GANCICLOVIR.

10.1097/00007890-199904150-00506 ◽

1999 ◽

Vol 67 (7) ◽

pp. S126

Author(s):

Nathalie Turgeon ◽

Jay A. Fishman ◽

Maureen Doran ◽

Nesli Basgoz ◽

Nina E. Tolkoff-Rubin ◽

...

Keyword(s):

Liver Transplant ◽

Oral Ganciclovir ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽

EFFECT OF ORAL ACYCLOVIR OR GANCICLOVIR THERAPY AFTER PREEMPTIVE INTRAVENOUS GANCICLOVIR THERAPY TO PREVENT CYTOMEGALOVIRUS DISEASE IN CYTOMEGALOVIRUS SEROPOSITIVE RENAL AND LIVER TRANSPLANT RECIPIENTS RECEIVING ANTILYMPHOCYTE ANTIBODY THERAPY1

10.1097/00007890-199812270-00036 ◽

1998 ◽

Vol 66 (12) ◽

pp. 1780-1786 ◽

Cited By ~ 37

Author(s):

Nathalie Turgeon ◽

Jay A. Fishman ◽

Nesli Basgoz ◽

Nina E. Tolkoff-Rubin ◽

Maureen Doran ◽

...

Keyword(s):

Liver Transplant ◽

Oral Acyclovir ◽

Transplant Recipients ◽

Cytomegalovirus Disease ◽

Intravenous Ganciclovir ◽

Ganciclovir Therapy ◽

Antilymphocyte Antibody ◽